(Q70920679)
Statements
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer (English)
Berman E
Wittes RE
Leyland-Jones B
Casper ES
Gralla RJ
Howard J
Williams L
Baratz R
1 December 1983